Following a landmark €1.7 Billion financing round at an €11.7 Billion valuation led by ASML, Mistral AI has systematically expanded its operational footprint across the global healthcare ecosystem. This expansion operates across three core domains: high-performance sovereign infrastructure partnerships, community-led academic domain specialisation and direct commercial integration across clinical operations, hospital administration, and pharmaceutical research and development